I agree SAMR is unlikely, if Morgan Stanley is correct there will be new regulations soon and all companies including a2m will need to resubmit and undergo site inspections.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025